The COVID-19 pandemic has shown the very best of science, how fundamental it is to all of us, and how determined and pioneering individuals and companies can provide such transformative solutions, particularly when they work together.
Director, Scientific Research
We recognise the harm caused by tobacco and are on a journey to rapidly transform ourselves by reducing the health impact of the business and, ultimately, building A Better Tomorrow™. We’re sharing our progress and focusing on key areas — innovation, consumer choice, and actively participating in Tobacco Harm Reduction on a global scale.
But change is a constant and there is always more to be done. We will continue to be the driving force behind world-class science in the New Category space, investing in our people and facilities to accelerate progress. We will continue to push forward using technology and disruptive innovations that can make a positive difference to peoples’ lives. And we will continue to seek new opportunities for our business and consumers, boldly entering new product spaces.
The launch of our first CBD vaping product in January 2021 was a significant milestone for us and I’m proud of the way my team has embraced this new and exciting product space.
We are the first truly global vaping company to launch a CBD vaping product, a great example of the BAT ethos in action — being bold, fast, responsible, diverse and empowered. It was developed using our company’s global vaping expertise, world-class science, product stewardship, and robust supply chain sourcing, and it represents the first big step on our journey Beyond Nicotine.
Our biotech subsidiary’s COVID-19 candidate vaccine is another significant milestone. Our experts in Kentucky, US, have had two major achievements by progressing into clinical trials with candidate vaccines for both seasonal flu (quadrivalent influenza) and COVID-19. There’s still a long way to go but our progress is significant.
Proud of our People
I have long said how valuable it is to have an inspired culture of curious, agile and forward-thinking people, and that’s a source of genuine differentiation for BAT. This feels more important to me than ever. I am so proud of our diverse community of experts, with myriad skills, perspectives and expertise, whose scientific research is powering our technology and product innovation. The more we can achieve, the faster we can help make this a reality and truly make a difference to Tobacco Harm Reduction on a global scale.
*Based on the weight of evidence and assuming a complete switch from cigarette smoking. These products are not risk free and are addictive.
Our products as sold in the US, including Vuse, Velo, Grizzly, Kodiak, and Camel Snus, are subject to FDA regulation and no reduced-risk claims will be made as to these products without agency clearance.